Clinical Trial Update: Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 mechanistic trial comparing norepinephrine versus angiotensin II in septic shock; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Giapreza (Angiotensin II)
• Levophed (norepinephrine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Septic Shock | Phase 4 | Status: NOT_YET_RECRUITING